A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against COVID-19 has shown strong antibody growth in a majority of the study’s participants, the Russian Direct Investment Fund said on Monday.
The data was collected from 20 people who took part in a 100-person study in Azerbaijan that began in February. They first received the AstraZeneca shot followed by the one-dose Russian-made Sputnik Light shot 29 days later, RDIF said.
“According to the results of the interim analysis, a fourfold or higher increase in neutralising antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85% of the volunteers on the 57th day of the study,” RDIF said.
Written by
This news first appeared on https://techncruncher.blogspot.com/2021/09/study-shows-antibody-growth-from.html under the title “Study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix”. Bolchha Nepal is not responsible or affiliated towards the opinion expressed in this news article.
